Live Breaking News & Updates on Antengene corporation limited

Stay informed with the latest breaking news from Antengene corporation limited on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Antengene corporation limited and stay connected to the pulse of your community

Antengene Presents Four Preclinical Posters at AACR 2024

Antengene Presents Four Preclinical Posters at AACR 2024
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

China , Beijing , California , United-states , San-diego-convention-center , Hong-kong , Macau , South-korea , Australia , Taiwan , Shanghai , San-diego

Antengene Presents Four Preclinical Posters At AACR 2024

Antengene Presents Four Preclinical Posters At AACR 2024
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

China , San-diego , California , United-states , Australia , Shanghai , Singapore , Beijing , Taiwan , Hong-kong , South-korea , Macau

Antengene Presents Four Preclinical Posters at AACR 2024 - Thailand Business News

Antengene Presents Four Preclinical Posters at AACR 2024 - Thailand Business News
thailand-business-news.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thailand-business-news.com Daily Mail and Mail on Sunday newspapers.

China , Thailand , United-states , Hong-kong , Australia , Beijing , Shanghai , Taiwan , South-korea , Macau , San-diego , California

Antengene Announces Full Year 2023 Financial Results, Highlights Clinical Progress Across First-in-Class, Best-in-Class Pipeline

Antengene Announces Full Year 2023 Financial Results, Highlights Clinical Progress Across First-in-Class, Best-in-Class Pipeline
philippinetimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from philippinetimes.com Daily Mail and Mail on Sunday newspapers.

Colorado , United-states , Taiwan , Texas , South-korea , Macau , Singapore , China , Shanghai , Hong-kong , Australia , American

Antengene Announces Inclusion of XPOVIO (selinexor) in 2023 China's National Reimbursement Drug List

Antengene Announces Inclusion of XPOVIO (selinexor) in 2023 China's National Reimbursement Drug List
philippinetimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from philippinetimes.com Daily Mail and Mail on Sunday newspapers.

Singapore , China , Macau , Australia , Taiwan , South-korea , Shanghai , Hong-kong , Jay-mei , Asia-pacific , Peter-qian , Hong-kong-stock-exchange

Antengene Announces Inclusion of XPOVIO® (selinexor) in 2023 China's National Reimbursement Drug List

Antengene Announces Inclusion of XPOVIO® (selinexor) in 2023 China's National Reimbursement Drug List
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Australia , Hong-kong , China , Macau , South-korea , Shanghai , Taiwan , Singapore , Asia-pacific , Jay-mei , Peter-qian , Karyopharm-therapeutics-inc

Antengene Announces the Study of Anti-CD24 Monoclonal Antibody ATG-031 Dosed Its First Patient in the United States

Antengene Announces the Study of Anti-CD24 Monoclonal Antibody ATG-031 Dosed Its First Patient in the United States
bignewsnetwork.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bignewsnetwork.com Daily Mail and Mail on Sunday newspapers.

Texas , United-states , Australia , Singapore , South-korea , Macau , Taiwan , Shanghai , China , Hong-kong , American , Jay-mei

Antengene Announces XPOVIO® Regulatory Approval in Macau for the Treatment of Relapsed and/or Refractory Multiple Myeloma

Antengene Announces XPOVIO® Regulatory Approval in Macau for the Treatment of Relapsed and/or Refractory Multiple Myeloma
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Macau , Taiwan , Shanghai , China , Australia , Hong-kong , Singapore , South-korea , Chinese , Peter-qian , Asia-pacific , Jay-mei

Antengene Presents Encouraging Clinical Data from Four Pipeline Programs at the 2023 R&D Day

/PRNewswire/ -- Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading commercial-stage innovative, global biopharmaceutical company dedicated to...

China , South-korea , Taiwan , Australia , Hong-kong , Beijing , Singapore , Shanghai , Chinese , Peter-qian , Jay-mei , Asia-pacific

Antengene Presents Encouraging Clinical Data From Four Pipeline Programs At The 2023 R&D Day

Antengene Presents Encouraging Clinical Data From Four Pipeline Programs At The 2023 R&D Day
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

China , Hong-kong , Taiwan , Australia , Shanghai , Beijing , Singapore , South-korea , Chinese , Jay-mei , Peter-qian , Asia-pacific